Furthermore, we tested the necessity of GPER signaling for LNS8801-induced AML inhibition by using the GPER-specific antagonist G-36 and found that G-36 did not prevent the antiproliferative effect of LNS8801 (Fig. 3C and D). Here, GPER1 is linked to acute myeloid leukemia.